Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

platinum-resistant ovarian cancer

Women's_Health

Women’s Health Today—April 15, 2026

This biweekly Women’s Health video recap highlights regulatory advances,…

Onco_background

Oncology Today—April 14, 2026

This week’s Oncology update highlights regulatory progress, pivotal clinical…

Onco_background

Oncology Today—April 6, 2026

This week’s Oncology update highlights regulatory progress, late-stage clinical…

Onco_background

Oncology Today—February 16, 2026

This week's Oncology update covers regulatory actions, clinical trial progress,…

Oncology News

Oncology Video Recap—January 5, 2026

This Oncology video recap covering news from the last thre weeks brings…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Hematology Today—May 25, 2026
Oncology Today—May 25, 2026
Lucid Diligence Brief: Genethon and Ampersand Biomedicines AAV Partnership
Lucid Diligence Brief: Gilead To Acquire Tubulis to Expand Oncology ADC Pipeline
Vaccines Today—May 22, 2026

Tags

AAV-based gene therapies AB Science adaptive design ambient scribe American Academy of Pediatrics American Society of Clinical Oncology Anesthesia and Brain Function ARIKAYCE avian influenza B-cell architecture analysis breast cancer genomics cancer care cancer vaccines Cardiovascular strategy Chemotherapy clinicaltrials competitive advantage Congenital disorder of glycosylation CVC datasecurity Diabetes drug development digital health innovation digital pill drug development enterprise AI Eton Pharmaceuticals fair pricing FDA respiratory approvals Fruzaqla Global obesity market Global women’s health market google ventures HBICE HeartFlow Infectious disease preparedness Medical Care Technologies mental health Pain patient centricity Plasma value chain Revolution Medicines SciSparc Tecvayli US health crisis VOICE ASSISTANT

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Hematology Today—May 25, 2026
Oncology Today—May 25, 2026
Lucid Diligence Brief: Genethon and Ampersand Biomedicines AAV Partnership
Lucid Diligence Brief: Gilead To Acquire Tubulis to Expand Oncology ADC Pipeline
Vaccines Today—May 22, 2026

TAGS

AAV-based gene therapies AB Science adaptive design ambient scribe American Academy of Pediatrics American Society of Clinical Oncology Anesthesia and Brain Function ARIKAYCE avian influenza B-cell architecture analysis breast cancer genomics cancer care cancer vaccines Cardiovascular strategy Chemotherapy clinicaltrials competitive advantage Congenital disorder of glycosylation CVC datasecurity Diabetes drug development digital health innovation digital pill drug development enterprise AI Eton Pharmaceuticals fair pricing FDA respiratory approvals Fruzaqla Global obesity market Global women’s health market google ventures HBICE HeartFlow Infectious disease preparedness Medical Care Technologies mental health Pain patient centricity Plasma value chain Revolution Medicines SciSparc Tecvayli US health crisis VOICE ASSISTANT

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy